Improved vision with less eye injections for patients after primary endpoints met in trials
The primary endpoints in two clinical trials investigating drug aflibercept 8 mg with 12 and…
September 9, 2022 - 3 minutes
Bayer
Clearance given to clinical trial with potential to change course of brain disease
A trial to look at gene therapy, BV-01, for Huntington’s Disease has been given the…
August 24, 2022 - 3 minutes
Ginkgo acquires Zymergen for $300M and picks up Bayer facility for $83M
U.S. cell programming company Ginkgo Bioworks has signed definitive agreements to acquire two teams and…
July 26, 2022 - 5 minutes
Expansion into Europe for BlueRock Therapeutics
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has…
June 10, 2022 - 2 minutes
Big Pharma Strikes Megadeals In Targeted Protein Degradation
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
November 12, 2021 - 5 minutes
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
June 8, 2021 - 5 minutes
Women’s Health Gains Traction as Bayer Pays €736M for UK Firm
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
August 18, 2020 - 3 minutes
Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding
Bayer and the French biotech company Meiogenix will work together to advance the development of…
February 10, 2020 - 3 minutes
Bayer Launches Israeli Company to Develop Viruses Against Crop Disease
Bayer is backing the launch of the Israeli biotech Ecophage, which will develop environmentally friendly…
July 11, 2019 - 2 minutes
The Race to Get CRISPR to the Clinic: Hope Versus Hype
In 2016, German pharma giant Bayer took a bold step and decided to partner with…
June 28, 2018 - 7 minutes
“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech
Some careers take on an international scope and span the breadth of big players in…
June 20, 2018 - 9 minutes
After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering
Cellectis spin-off Calyxt has launched a €41M follow-on round after settling the lawsuit it recently brought against Bayer…
May 17, 2018 - 2 minutes
